Summary: Significant advances have been made in recent years in improving animal stocks by selective breeding. However, existing selection techniques still rely on laborious and time-consuming progeny-testing programs and often depend on subjective assessment of the phenotype. New techniques in molecular genetics are being developed, aimed at the isolation and identification of DNA markers linked to genes for economically important production traits and disease resistance. When available, these markers will provide animal breeders with an objective test system to identify, at birth or even earlier, animals carrying desirable genes. This review outlines some of these new techniques and how they may be applied to the animal industries. Consideration is also given to some of the recent advances in our understanding of the immune system and of possible mechanisms of genetic control of animal disease resistance or susceptibility. The current knowledge of major histocompatibility complex (MHC) and non-MHC associated disease resistance/susceptibility in domestic animals is summarised and mechanisms which may be responsible for these associations are presented. Genes that control such factors as macrophage activation, cytokines, cytokine receptors and yô-T cell receptors are also presented as potential candidates for analysis in genetic disease association studies. Ultimately, the goal will be to identify genes or DNA markers which can be used to select for or to genetically engineer disease resistance and enhanced production traits.
INTRODUCTION
The decade of the 1980s has seen the rapid development of a technology which has the potential to revolutionise domestic animal breeding. This advancement has come about as a result of the discovery and characterisation of a large number of polymorphic regions in the human genome and has led directly to the possibility of identifying and cloning genes that were previously undetectable without prior knowledge of the protein encoded by a given gene. The cloning of DNA from polymorphic regions now provides an array of DNA marker probes which can be used as tools to trace inheritance within families. Using these probes as genetic markers, closely linked genes can be followed as they segregate within family pedigrees. This technology provides a general method for locating genes responsible for inherited diseases and for predisposition to cancers in man (32, 33), as well as genes determining disease resistance and other economically important production traits in domestic animals.
Human DNA markers have recently been cloned that allow the detection of genes causing some of the more common inherited diseases, such as Duchenne muscular dystrophy (DMD) (74) , and cystic fibrosis (119, 120) . These examples represent triumphs for "reverse genetics", the characterisation of genetic mutations by locating and cloning mutant genes through their linkage to polymorphic DNA markers. This indirect method of identifying the altered gene responsible for an inherited disease, such as DMD, eliminates the need for prior knowledge of the nature of the disease and the specific protein defect. Thus, with DMD it has been possible to "work backwards" to identify dystrophin as the muscle protein deficient in affected individuals (65) .
The animal industries are in a position to greatly benefit from the knowledge gained as a result of this research in humans. Although the problems facing animal breeders are significantly different from those encountered by human geneticists, genetic markers can be used to rapidly identify genes of economic importance, thereby enabling cloning and characterisation. In addition, it is possible with these techniques to define a series of DNA markers closely linked to major genes which determine production traits or disease resistance. Such markers can be used to predict at birth or even in pre-implantation embryos (for example, immediately prior to embryo transfer) the phenotype of an animal, which until now could not be assessed until maturity.
POLYMORPHIC DNA MARKERS FOR SELECTION OF ECONOMICALLY IMPORTANT TRAITS
There have been suggestions in the literature over many years that it should be possible to identify in the genome of domestic animals quantitative trait loci (QTL) that have major effects on production traits (16, 45, 46, 79) . The rationale behind this approach is to establish a way of "tagging" specific segments of chromosomes with polymorphic markers. One can then follow the segregation in pedigrees of the tagged chromosomal regions and associate the marker with the presence of desirable traits such as high milk production, low fat content of meat, high wool yield or decreased wool fibre diameter. Gelderman et al. (47) demonstrated the practicality of this approach in dairy cattle using protein polymorphisms in blood group antigens and common blood and milk proteins as markers for individual chromosomal segments. By following the inheritance of these markers from sires to daughters, Gelderman and his colleagues were able to suggest that a considerable portion of the genetic variance for milk production is due to genes situated within a few chromosomal regions. Using a similar approach, Beever et al. (17) demonstrated the effects of tagged chromosomal regions on fat thickness and rib-eye area in beef cattle. There are two logical applications to this technique of tagging chromosomal segments with polymorphic markers. Firstly, the identification of chromosomal markers that are tightly associated with the presence of a desirable trait would allow the immediate identification of animals carrying the favourable gene(s) for the trait without having to identify the gene itself. In practice it should be possible to establish panels of markers to test individuals in a breeding program at birth rather than having to go through the time-consuming and costly progeny-testing procedures currently in use. Secondly, these chromosomal markers could be used to identify the gene(s) which directly influences production traits in order to clone and characterise the relevant gene and its product. Knowledge of the actual gene and its product could then suggest ways to genetically or physiologically intervene to increase animal production. Until recently, the use of DNA markers to identify important genes was not considered practical due to the lack of a sufficiently large panel of polymorphic markers to tag all chromosomal segments at regular intervals. However, advances in molecular genetics have provided the solution to this problem by taking advantage of the extensive amount of DNA sequence polymorphism that exists between genomes of individuals of the same species (69) . Patterson et al. (108) and Lander and Botstein (77) have demonstrated that in tomatoes several QTL, controlling such traits as fruit mass, concentration of soluble solids and fruit pH, could be identified. These are landmark papers proving that it is possible to unravel the complex genetics of polygenic quantitative traits using polymorphic markers that map all chromosomes in the genome.
RFLP analysis
The term RFLP (restriction fragment length polymorphism) is now a common word in the dictionary of the geneticist, and RFLP analysis is an important technique for gene identification and characterisation. RFLPs are detected as differences in the size of DNA fragments produced after digestion with specialised endonucleases (restriction enzymes) which cleave DNA only when a particular nucleotide sequence (on average three to six base pairs) is present. This unique base sequence recognised by a restriction enzyme is known as a restriction site, and variation in the nucleotide sequence is reflected in differences in the size of the fragments detected on Southern blots (Fig. 1) .
RFLPs, or site polymorphisms, are present in both genes and "anonymous" DNA segments. When an expressed gene codes for a product that may be directly related to the disease or trait under study, it is referred to as a "candidate gene". A candidate gene for wool production, for example, might be one of the keratin genes. It may be possible to correlate disease resistance or susceptibility with polymorphisms associated with alleles of the major histocompatibility complex (MHC) gene cluster, or in other genes coding for products directly influencing the immune system (e.g. cytokines).
Candidate genes offer a good starting point for linkage studies. However, it is unlikely that enough is known about the genetic mechanisms controlling most traits to restrict research to these genes. Full advantage needs to be taken of RFLPs present in anonymous DNA segments as well. It is well known that a large amount of base sequence variation exists throughout the genome (69) , and almost 1,900 human probes have been cloned which identify RFLPs present in expressed genes as well as in anonymous segments of genomic DNA (73) . A second type of polymorphism, referred
FIG. 1
Segregation of an RFLP detected by a probe for an ovine MHC class II DQA gene (132, 133) on Southern blot analysis 1A. Digestion of genomic DNA with the restriction enzyme EcoRI will produce a 3.4 kb fragment when the polymorphic restriction site E2 is absent, or 1.6 kb and 1.8 kb fragments when E2 is present, however, only the 3.4 kb and 1.6 kb fragments will be recognised by the probe and seen as hybridising bands on the autoradiograph.
1B.
The RFLPs associated with an ovine MHC class II probe can be seen segregating in a family in which the father is homozygous for the presence of the polymorphic restriction site E2, having only the 1.6 kb fragment (allele A2), and the mother is an A1 ,A2 heterozygote having one 1.6 kb fragment, when E2 is present, and one 3.4 kb fragment (allele A1) when E2 is absent. Sib 1: inherited allele A2 from the father and Al from the mother. Sib 2: inherited A2 from both the father and the mother.
The polymorphisms or DNA sequence variations shown in Fig. 1A and 1B are detected as differences in fragment sizes on Southern blots following digestion of genomic DNA with a restriction enzyme. The DNA fragments that are generated are separated electrophoretically according to size on an agarose gel and transferred to a nylon membrane by capillary blotting (Southern blot). Specific DNA fragments are visualised by hybridising the membrane with a radioactively labelled cloned DNA sequence acting as a probe which will bind specifically to homologous DNA segments on the Southern blot. The blot is then exposed to autoradiographic film for several days, and following development, hybridising DNA fragments are seen as dark bands.
to as "variable number tandem repeats", or VNTRs, has recently been described in the human genome (98) . These polymorphisms, generated as a result of differences in the length of DNA between two restriction sites, are usually due to variation in the number of small, tandemly repeated DNA sequences found between the restriction sites. By definition, the tandem repeat sequences associated with a specific VNTR polymorphism define a unique locus within the genome (98) . However, as many VNTRs display partial nucleotide sequence identity, the total sum of related VNTR sequences distributed across the genome may contribute to the complex, multilocus "genetic fingerprint" characterised by Jeffreys et al. (70) as being unique for each individual within a species. Numerous studies have already been undertaken to define RFLPs that could serve as markers for likely candidate genes in cattle and sheep (see Table I ). However, the isolation of a large series of RFLP and VNTR marker probes from the genomes of domestic animals similar to those cloned from the human genome will be required for marker-assisted trait selection, especially as little is known about the mode of inheritance of most of the traits, and because important production characteristics are likely to be polygenic and/or genetically heterogeneous.
Beckman (14) has recently suggested that in view of the high number of animals that will require testing in a large-scale marker-assisted trait selection programme and the cost and time involved in conventional Southern blot analyses, synthetic probes based on short, unique, allele specific DNA base sequences should be developed. These probes, referred to as oligonucleotide probes, could easily be combined with some of the newer DNA analysis techniques, such as polymerase chain reaction (PCR) amplification (96) , to streamline DNA testing procedures. Such an approach has recently been employed by Medrano and Aguilar-Cordova (86) to rapidly characterise x-casein variants in dairy calves.
Developing a genetic map for domestic livestock
Hand in hand with the development of a series of polymorphic markers for identifying genes controlling traits of economic importance is the need to create physical and linkage maps of these markers. As well as indicating the location of major genes controlling a specific trait, it is necessary to have some idea of the physical relationship of the various markers to ensure relatively complete and uniform coverage of the genome. Donis-Keller et al. (36) have pointed out that 500 polymorphic probes isolated at random from human genomic libraries were not evenly distributed on all human chromosomes, there being a disproportionate representation of RFLPs located on the larger chromosomes. Furthermore, 39% of the most informative probes were located near the ends of the chromosomes (36). Thus, as marker probes are isolated for possible use in domestic animals, it is important to simultaneously order the probes relative to one another via linkage analysis (103) and to physically map at least some of the markers to specific chromosomes using in situ hybridisation techniques (24) or well characterised somatic cell hybrid panels (91, 137 ). These mapped markers will then serve as anchor points to which other markers can be related by recombination analysis.
At the present time, approximately 140 genes have been mapped in cattle and/or sheep. Most of these genes have been assigned to syntenic groups (groups of genes that are retained or lost concordantly from the hybrid cell lines) using somatic cell hybrid panels (23, 67, 71, 124, 125, 126, 127, 128 and reviewed in 41). Recently several groups of researchers have begun assigning the various syntenic groups to specific chromosomes in sheep and cattle (see Table II ). The question of how many RFLP markers are necessary to map the genome of each domestic animal species needs considerable thought and experimentation; the answer will depend on a number of factors, including the size and structure of the animal families to be studied, the level of polymorphism detected by the markers and the polygenic character of the traits being studied. Botstein et al. (20) have suggested that the optimum placement of RFLP markers, i.e. approximately 20 cM apart (1 cM = 1% recombination or approximately 10 6 base pairs), ensures accurate detection by linkage analysis of genes within 10 cM of the markers. Given that the estimated size of the human genome is 3300 cM, this would require about 150 probes to ensure adequate coverage of all chromosomes. Schumm et al. (130) have shown that 150 probes, chosen for the high degree of polymorphism they reveal and for their relatively uniform distribution on all chromosomes, cover approximately 95% of the human genome. However, this number of probes is only a fraction of the number that will need to be screened. Most of the probes isolated from a human genomic library by Schumm et al. (130) either represented non-polymorphic regions or hybridised to DNA sequences scattered throughout the genome resulting in allelic patterns too complex to be useful. Only 30% of the probes were polymorphic (at least 2 alleles), with 11% revealing enough polymorphism to be informative in establishing a human genetic linkage map. As the distribution of isolated probes is likely to be random, with tight clusters and gaps appearing, Lange and Boehnke (78) have estimated that 700-800 probes is a more realistic figure to ensure a uniform distribution of markers 20 cM apart on the 22 human autosomes.
A number of research groups has developed several strategies that allow large numbers of DNA probes that recognise polymorphic loci within the human genome to be rapidly identified. A genomic DNA library of randomly cloned genomic fragments inserted into bacteriophage or cosmid cloning vectors should, if completely representative, contain the entire nucleotide sequence of the genome of the organism from which the DNA was first isolated. In theory, genomic fragments isolated from individual bacteriophage or cosmid clones should each represent a unique portion of the genome from which the DNA was derived. In practice, this is not the case, as during the cloning and subsequent amplification of a genomic library, sequence bias may be generated, with fragments bearing certain nucleotide sequences being under-represented, or even absent from the library (see 172 for details). More relevant, however, is the observation that many of the VNTR loci dispersed throughout the genome are related by partial sequence homology (70) . As a result, it is highly likely that genomic inserts isolated from many recombinant clones will display complex patterns of cross-hybridisation when assayed against total genomic DNA using Southern blot analysis.
One strategy developed to isolate single-copy genomic inserts from bacteriophage libraries is "negative selection" (38, 72, 130) . Recombinant bacteriophage are plated on bacterial lawns and hybridised to 32 P-labeled total genomic DNA using conventional methods (18) . Positively hybridising bacteriophage have inserts containing highly repetitive sequences and are eliminated from further screening, while negative bacteriophage, containing putative single-copy sequences, are subject to several additional rounds of screening. Genomic inserts isolated from negative bacteriophage are then hybridised to total genomic DNA, isolated from a number of unrelated individuals. Genomic DNA used in Southern blot analysis is first digested with a selection of DNA restriction endonucleases. The use of a small sample size and a limited number of restriction enzymes makes it possible to select genomic inserts which recognise polymorphic alleles that occur with high frequency at a particular locus, and, therefore, will be most informative for genotyping.
By selectively pre-screening 80,000 plaques from a human genomic DNA library cloned in bacteriophage X Charon 4A, Donis-Keller and colleagues isolated 1,025 "repeat-free" clones, of which 680 contained single-copy human sequences, determined by Southern blot analysis (130) . Of the single-copy inserts screened, 331 (49%) were polymorphic, with 151 (22%) recognising three or more alleles at a single locus. Screening randomly selected bacteriophage clones directly by Southern blot analysis, after labeled clones had been hybridised in solution with an excess of human DNA, was similarly a successful method for detecting clones that recognised polymorphic single loci, although the isolation of clones that recognised highly polymorphic loci was significantly less efficient with this method (130) . Pre-screening bacteriophage clones with total human DNA revealed that 0.9% of clones contained unique DNA sequences, a figure that agrees well with the 1% previously reported by Kao et al. (72) , but which is considerably higher than that obtained by others (38). Regardless of variability, it is significant to note that in the latter study cited, 12 out of 13 clones isolated from a screen of 8,000 bacteriophage recognised a single locus, and all were polymorphic.
An alternative approach exploits the partial sequence homology that exists between different VNTR loci (70), whereby one repetitive element can be used to screen DNA libraries to isolate other related elements that represent single loci (171). Nakamura and co-workers used a variety of oligonucleotide probes, corresponding to the "core" sequence of repetitive elements associated with a number of different cloned DNA's, to screen a human cosmid library under hybridisation and washing conditions of low stringency (98) . Over 1,000 candidate clones were isolated per genome equivalent; surprisingly, fewer than 4% of a sample of 100 clones analysed showed crosshybridisation between the oligonucleotide probes used. The subsequent characterisation of 372 cosmid clones by Southern blot analysis revealed that 77 (21%) contained sequences that detect new VNTR loci, over 90% of which have three or more alleles (98) . The screening of unselected cosmids cloned for the presence of VNTR loci contained within cloned insert DNA was five-to ten-fold less efficient than oligonucleotide pre-screening. Interestingly, oligonucleotide screening of a human genomic DNA library propagated in bacteriophage failed to identify phage carrying VNTR loci, probably reflecting the inability of bacteriophage containing repetitive DNA to grow well on certain bacterial strains (98, 172) .
From a technical angle, it should be pointed out that in genomic inserts isolated from bacteriophage or cosmid clones, sequences recognising VNTR loci probably represent only a minor portion of the total cloned insert, which may be as large as 30,000 base pairs. It is, however, not necessary to establish by sequencing the core nucleotide motif for every VNTR repeat isolated. By simply subcloning a repeat-containing DNA fragment without the flanking genomic sequences into a more versatile cloning vector (e.g. a plasmid), one can economically establish a battery of VNTR-specific probes, identified by negative-selection or oligonucleotide screening, with which to perform genetic linkage analysis.
Assuming that the genome of domestic animals is approximately the same size as that of humans and extrapolating from the human experiences to establish a set of markers allowing identification of genes of economic importance for the animal industry, it is reasonable that between 200 (36) and 750 (78) informative, highly polymorphic probes will need to be isolated and characterised from among the thousands screened. If the probes for sheep and cattle cross-hybridise sufficiently, laboratories working with these two species will be able to share markers. Accumulation of a large number of polymorphic markers suitable for identifying genes that control production traits or disease resistance represents an ambitious, though a daunting and arduous task. Clearly, the key to success is a co-ordinated, collaborative approach involving many laboratories throughout the world.
GENETIC SELECTION FOR DISEASE RESISTANCE
Breeding and selection for resistance to disease, especially parasitic infections where, to date, vaccination has had limited success, has been an age-old objective in animal research. Several examples of breed-specific variations within cattle and sheep clearly point to the presence of genetically controlled elements responsible for differences in disease resistance, although in most cases the underlying mechanisms responsible for these differences are unknown. For example, the Red Masai sheep established in areas of Africa endemic for Haemonchus contortus show resistance to infection whereas European breeds and Merino sheep in Australia are much more susceptible to infection (13, 113) . Similarly, Bos indicus (African breeds) cattle are much more resistant to ticks {Boophilus microplus) than Bos taurus (British breeds). In this case resistance is correlated with immediate hypersensitivity reactions and associated grooming by the host (168) . There are also breed-specific differences with respect to trypanosomiasis. Experiments in West Africa indicate that Zebu cattle have a higher mortality subsequent to experimental trypanosome infection than does the "trypanotolerant" N'dama breed (97) . Genetic variations within breeds of sheep in natural resistance to H. contortus (A, 166, 167) , Trichostrongylus colubriformis (104, 169) , mixed nematode infection (165) , footrot (141) , fleece rot and fly strike (85) and scrapie (40) have also been shown to exist and are being exploited to establish resistant lines of sheep (4, 12, 39, 173) . Various quantitative and practical considerations of selective breeding for disease resistance have recently been reviewed by Albers and Gray (3), Barger (13), Lewin (81) and Shook (136) .
From information gained from studies of human disease associations, studies in animals to identify immunologically based disease resistance genes have concentrated primarily on possible associations with MHC genes. Recently Wakelin and Blackwell (164) published an excellent review of progress made in identifying genes responsible for resistance to bacterial and parasitic infections. While it is beyond the scope of this review to summarise their findings, two major points emerge: (1) resistance to infection may act at several levels, each controlled by different and independent mechanisms. In particular, during many bacterial and protozoal infections, resistance can be manifest in an early T cell and memory-independent phase, and a later T cell memory-dependent phase, and (2) while MHC associations can be detected in the progression of a disease towards healing or dissemination, non-MHC genes are generally involved in controlling initial resistant or susceptible phenotypes.
Although various components of the immune system have generally been the major focus of disease resistance research, other non-immune, biochemical and physiological mechanisms must also be considered as potential candidates for genetic control of disease. For example, the PrP gene codes for a glycoprotein which forms the major component of scrapie-associated fibrils (101) that are characteristic of the fatal neurological disease in sheep (66) . Recent work by Hunter et al. (66) in Cheviot sheep has identified an RFLP of the PrP gene that is linked to (and may be identical with) the sheep Sip gene that determines the host's response to injection of Scrapie brain extract (SSBP/1). The exact relationship between the PrP gene product and the resistance to scrapie in Sip sA/sA sheep remains to be determined.
In parasite infections, genetically controlled non-immunological factors may interact in a variety of ways to prevent full or partial development of a pathogen in a particular host. Some of the best characterised examples of this type of innate resistance are due to the absence in the host of molecules which serve as receptors for complementary molecules on the pathogen; the invasion of host cells is thereby prevented. These examples include the Duffy blood group antigen on the surface of red blood cells necessary for the invasion of Plasmodium vivax (139) and the receptor molecules on the gut mucosal surface of pigs required for the colonisation of E. coli (123) . Parasite survival in the host may also depend on the presence of adequate nutritional and developmental factors to allow parasite maturation in the host's environment or on the absence of products in the host that are toxic to the parasite, such as lytic factors in the serum of trypanosome resistant cattle (154) . Although physiological or biochemical factors may be the genetic basis for resistance or susceptibility, the mechanism of resistance may still be a function of the immune system. For example, the slower development of a parasite in an unfavourable host environment may allow the generation of a protective immune response before the onset of disease. As numerous factors can lead to genetically controlled resistance to disease, a thorough understanding of the nature of these resistance mechanisms is likely to suggest obvious candidate genes to be investigated for genetic linkage studies.
IMMUNOLOGICAL CONTROL OF DISEASE RESISTANCE -MHC AND NON-MHC DISEASE ASSOCIATIONS
The aims of the following sections are to present examples of genetically controlled disease resistance which may serve as models for future studies, to speculate on the immunological basis of MHC association with disease resistance and susceptibility, and to discuss recent immunological findings that may reveal an insight into non-MHC linked genetic control of disease.
The major histocompatibility complex Although many components of the immune system are potentially involved in the genetic regulation of disease resistance, the single most widely documented component is the MHC. In all species studied, the MHC gene family can be shown to contain two different clusters of genes, designated class I and class II, that code for cell surface glycoproteins involved in antigen presentation to T lymphocytes. The MHC region of humans (HLA) and mice (H-2) also contains genes, designated class III, that code for the serum complement components C2, C4A and C4B. The class III genes, as well as genes coding for cytochrome P450 (CYP21, steroid 21-hydroxylase), CYP21 pseudogene, a and ß tumor necrosis factor, the heat shock 70kD protein 1 and the properdin factor B (BF) are situated between the MHC class I and class II genes on human chromosome 6 (reviewed in 143). The large amount of diverse genetic information in this area and the fact that this region is characterised by reduced levels of recombination (detected as linkage disequilibrium) suggest that many as yet unknown genes closely linked to the MHC genes may have a crucial role in explaining the observed degree of association between certain MHC alleles and disease resistance or susceptibility. It is also interesting to note, in view of several reported associations between the MHC and reproductive traits (102, 148, 156) , that in humans (27, 151) and cattle (41, 75, 142) the genes for prolactin (PRL) and CYP21, an enzyme involved in the metabolism of several steroid hormones, are closely linked to the MHC genes. CYP21 also appears to be linked to the swine MHC (156) , and it is likely that this same linkage will be found in other species as well, considering the highly conserved nature of this region.
The human MHC class I region contains three loci (HLA-A, -B, and -C) that encode highly polymorphic glycoproteins present on the surface of most nucleated cells in association with ß2-microglobulin. These class I antigens function in the presentation of endogenously synthesised antigens (eg. viral and tumour antigens) to cytotoxic T lymphocytes which must "see" the foreign antigen in the context of self MHC class I molecules in order to effect an immune response (reviewed in 107). The major gene products of the human MHC class II region are the DR and DQ molecules, which are heterodimeric glycoproteins containing one a and one ß subunit. The a subunits of the DR and DQ molecules are encoded by the DRA and DQA1 genes and the ß subunit by the DRB1 (or DRB3) and DQB1 genes, respectively. Other genes in this class II cluster include DQA2 and DQB2 (formerly DXa and DXß), which do not appear to be expressed, DPA1 and DPB1 that encode the DP molecules and the DPA2 and DPB2 pseudogenes, DNA and DOB (reviewed in 19, 155). The MHC class II glycoproteins are less polymorphic than the class I molecules and are more restricted in their expression, being found primarily on the surface of B lymphocytes, macrophages, dendritic cells and activated T lymphocytes. MHC class II molecules on the surface of these antigen presenting cells serve as restriction elements for T cell receptor (TCR) molecules on the surface of helper T lymphocytes (reviewed in 107).
Recently the MHC regions of sheep (OLA) and cattle (BoLA) have been the focus of intense molecular characterisation. In cattle, there are at least 33 class I BoLA-A locus alleles (25). The use of human probes to identify BoLA class II loci provides evidence for the existence of several bovine genes homologous with human HLA class II genes, including one or two DQA and DQB genes and single copies of DRA, DOB and DNA (8, 9). No evidence for DP genes has been found in cattle (9), however bovine genes designated DYA and DYB have been described that have no obvious homologs in humans or rodents (8, 158). To date, a number of these bovine class II genes have been sequenced, including one DRA and one DQA gene (158) , two DQB genes, one DRB gene and two DRB pseudogenes (53, 95) . These genes all demonstrate a typical exon/intron organisation for class II genes, with conservation of cysteine residue positions, glycosylation sites and many other features present in human HLA genes. RFLP analysis of the bovine genome using human gene probes has revealed a high recombination frequency between class II subregions. This finding suggests that either the molecular distance between subregions in cattle is much larger than in humans or, alternatively, that there are recombinational hot spots in the class II region (8).
In our laboratory, initial characterisation of the sheep MHC region focused on structural studies of the MHC antigens utilizing a panel of monoclonal antibodies directed against OLA class I and class II surface molecules (51, 115). Studies using these monoclonal antibodies have revealed the existence of three class I loci and up to four class II loci. N-terminal amino acid sequencing has identified DQa-and DRalike molecules and also the presence of numerous ß-polypeptides with indeterminate homology to the N-terminal region of the class II genes of humans and mice (114, 116) .
Recent work in this laboratory has concentrated on the molecular characterisation of the OLA class II region. Southern hybridization studies of sheep genomic DNA using human class II probes (133) , combined with RFLP analysis of selected families of sheep (132) , indicated that the ovine class II region contains single copies of DRA, DNA and DOB, one or two copies of DQA and DQB genes and at least three DRB genes, all of which are homologous with the respective human genes. Interestingly, in contrast to the situation in humans but similar to that in cattle (8), the number of genes in the DQ subregion in sheep appears to vary between one or two DQA and DQB genes depending on the haplotype. Whether the number of DRB genes is dependent on haplotype as it is in humans has not yet been determined in sheep or cattle. No ovine genes equivalent to those of the DP subregion in humans have been identified in sheep, which is consistent with the findings in cattle. Two OLA-DQA, one DQB and a DRB pseudogene from sheep have been sequenced and these genes have been shown to retain all the typical structural features of MHC class II genes (132) . Sequence data from the two sheep DQA genes suggest that these two genes are homologous to the human genes DQA1 and DQA2 (formerly DXa). Furthermore, Northern analysis suggests that both sheep DQA genes are transcribed, unlike the human DQA2 for which no evidence of expression has been found (132) . Comparison of sequence data suggests that the OLA class II genes are generally more homologous to the MHC genes in man than in the mouse, which is interesting from an evolutionary point of view.
MHC disease associations
In humans, where most MHC disease association studies have been conducted, there appear to be two categories of diseases associated with MHC genes. One category includes diseases that tend to run in families, have a polygenic basis and seem to have an autoimmune component (31). For example, there is considerable evidence for association between various HLA serological specificities and disease susceptibility, including HLA-B27 and ankylosing spondylitis, DR3 and coeliac disease, DR2 and multiple sclerosis and DR3 and/or DR4 and insulin dependent diabetes mellitus (reviewed in 150). The other category includes viral and bacterial diseases. Van Rood et al. (162) summarized studies showing that among descendants of Dutch emigrants who survived a series of typhoid and yellow fever epidemics in Surinam, South America, in the middle 1800s, individuals bearing the DR2 haplotype are more susceptible to malaria and individuals bearing a DR4 or DR6 haplotype are more resistant to typhoid and/or yellow fever. HLA haplotypes also appear to be implicated in determining susceptibility to infection and in determining whether an individual exposed to polio virus develops a severe case of poliomyelitis (161) or whether an individual exposed to Mycobacterium leprae (the susceptibility to which is determined by a non-HLA gene) develops the tuberculoid or lepromatous form of the disease (160).
There has also been considerable interest in the association between MHC genes and disease resistance in domestic animals (81, 100, 102, 159). The B-complex in poultry was the first MHC region described in domestic animals (reviewed in 76), and more recently the SLA in swine (reviewed in 156), BoLA in cattle and OLA in sheep (reviewed in 145), CLA in goats (99) and ELA in horses (reviewed in 11) have been documented. Most studies of genetic factors in disease resistance in cattle and sheep suggest an association of disease resistance/susceptibility with class I alleles or linkage to non-MHC genes located near the class I region (see Table III ). In many of these studies the specific associations were limited to single herds or flocks, and different allele associations were found when other groups of animals (different families or different breeds) were studied. This suggests that a non-MHC gene closely linked to the MHC region, rather than the specific MHC allele itself, is probably responsible for the disease resistance/susceptibility association. Care must also be taken with these studies to take into account sire or founder effects which can easily distort MHC association findings when inbred groups of animals are studied. 
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The predominance of class I associations in many of the studies cited in Table III is most likely due to the fact that serological typing reagents have been more widely available for class I than for the class II antigens. Now that the class II genes from many of the species have been cloned and these regions characterized at the molecular level (see previous discussion), studies using RFLP analysis to define haplotypes will make it possible to investigate disease resistance in terms of class II genes as well (11). Even though numerous studies in animals have presented some evidence for an MHC-associated resistance or susceptibility, further analysis is required to identify whether MHC alleles themselves are responsible for genetic predisposition, or whether closely linked non-MHC genes are involved. The availability of cloned molecular probes to identify complete haplotypes will eliminate the need to use (often incomplete) panels of serological typing reagents. It will be necessary to establish firm data using well characterised reagents and large family pedigrees in which the traits are segregating in order for MHC polymorphisms to be used as a basis of selection for disease resistance. It has been shown that non-responsiveness to certain antigens can be traced back to their failure to associate effectively with particular class II alleles (26, 131). Therefore, it is possible to speculate that disease resistance or susceptibility might result from the successful or unsuccessful binding of protective T cell epitopes to a particular MHC class I or II allele. In practice, most foreign antigens contain a wide variety of T cell epitopes making it unlikely that there would be complete nonresponsiveness to a complex antigen. However, the degree of responsiveness may be regulated by the availability of all combinations of T cell epitopes to associate with particular MHC haplotypes or by their preferential association with certain class I or class II molecules. This effect would be more pronounced where the foreign antigen of the disease pathogen closely resembles a host protein, thereby resulting in the prior deletion of T cells recognising the majority of T cell epitopes on the antigen through self tolerance (163) . A limited number of T cell epitopes on a complex antigen can also result from the presence of a large number of randomly repeated sequences on the antigen as is the case in the CS protein of malaria (52). In these cases, a close association between MHC and disease resistance/susceptibility may be expected.
Deletion of T cell clones that recognise class II molecules in association with epitopes derived from self antigen (= self tolerance) may create "holes in the T cell repertoire" (163) . In some individuals, T cells bearing receptors for complexes of class II molecules plus antigen from a disease pathogen may not be present since, if this complex resembles class II plus self antigens, it may have been previously deleted. As before, this effect would only be observed if the protective antigen consists of only a few T cell epitopes. In this case, associations between low response or susceptibility may be found with a particular MHC class II haplotype, but may also be due to any of the polymorphic self molecules of the individual. In addition, "holes in the T cell repertoire" may also occur through variations in the germline TCR genes and therefore have no relation to MHC and self tolerance. For example, deletion of the TCR-V ß 8 gene family in the germline DNA of certain mouse strains carrying the susceptible H-2 haplotype renders them resistant to collagen-induced arthritis (55).
Both differential associations of peptide fragments to MHC molecules and differential deletions of self-reactive T cell clones could be responsible for susceptibility to auto-immune diseases of bacterial or viral aetiology in certain individuals. However, in this case, the response to a single epitope of a self antigen may have a drastic effect and might result in auto-immune disease per se.
As mentioned previously, genes within the human MHC complex encode numerous proteins in addition to the class I and class II molecules, in particular components of the complement pathway (27, 143), monocyte A and B antigens (121) , tumour necrosis factor (117) and the heat shock 70kD protein 1 (129) . Abnormalities in these genes, or in other as yet undetected, closely linked non-MHC genes, may lead directly to "MHC-associated" disease patterns. To date, no such associations with these genes have been defined, however linkage to genes in the region of the MHC cluster may explain some of the inconsistent results observed in MHC disease associations (see Table III ).
Non-MHC disease resistance
So far, research in the area of disease associations in domestic animals has met with mixed success. In the 35 years since Whitlock (166, 167) demonstrated the heritability of Haemonchus resistance in sheep, few specific disease resistance genes have been clearly identified. As progress is made in our understanding of the immune system it is possible to imagine numerous ways in which genes controlling non-MHC elements might exert an effect. In addition to variable TCR complexes (and interaction of specific TCRs with specific MHC haplotypes), other potential regions of focus for future research should include genes regulating macrophage activation, differential regulation of cytokine production and cytokine receptor gene expression and the genes regulating variable expression of adhesion molecules involved in lymphocyte circulation and recruitment to sites of infection or inflammation.
In mice, the availability of congenic and recombinant inbred lines has made it possible to identify several dominant genes which control genetic resistance to specific infections. The best characterized of these is the Bcg/Ity/Lsh gene (or gene cluster) which is a dominant gene controlling resistance to Mycobacterium bovis (140), Salmonella (110) and Leishmania (21). To date these three genes have not been distinguished from one another, all mapping to a single locus on mouse chromosome 1 (109), and they appear to operate at the level of macrophage regulation (164) . This gene complex maps close to the genes for isocitrate dehydrogenase 1, 7-crystallin, fibronectin and peptidase-3 in the mouse (75, 152) , a region which has been conserved on bovine chromosome 8 (2, 174), so it will be interesting to determine whether a similar gene conferring resistance to bacterial infections can be identified in cattle and sheep. Salmonella infection and disease is also influenced by the Lps gene, linked to mouse chromosome 4 which determines sensitivity to bacterial endotoxin (29). Other specific genes identified in mice that influence bacterial or parasite resistance and susceptibility include Ric, a dominant gene for resistance to some rickettsial infections (54) and Lr which is involved in resistance to listeriosis (30). It appears that in many of the diseases where there is a single dominant gene influencing resistance, regulation occurs at the level of macrophage recruitment or activation and is T cell-independent. On the other hand, when there are clear strain specific differences in the immunological control of the later stages of infection, the complex genetic patterns often observed suggest the involvement of many genes and may reflect a variety of cellular interactions involved in the adaptive (T cell-dependent) immune response.
Recent advances in non-MHC linked disease control
Recent advances in immunology are giving us a better understanding of the mechanisms involved in disease control beyond the fine recognition events of the MHC system. Two areas in particular are the focus of major research efforts in the last few years and may have specific relevance to control of disease resistance.
The yò-T cell receptor (yò-TCR)
In early attempts to clone the classical aß-TCR a new gene was discovered coding for an alternative receptor on T cells now generally called the 7Ô-TCR (10, 22). The 7Ô-TCR does not have the same diversity in the variable region domains as the aß-TCR and is not always restricted in its antigen recognition to the classical MHC molecules (149) . 7Ô-TCR + T cells seem to be distributed preferentially in the epithelial and mucosal surfaces rather than in lymphoid tissue, which suggests that they function as the "first line of defence" against invading pathogens (22). The particular relevance of these cells to infectious diseases has been highlighted by their close association with the early events following bacterial and protozoal infections and their recognition of highly conserved antigens such as heat shock proteins from pathogenic organisms (68, 92) . Products from activated 7Ô-TCR + T cells have been shown to induce adhesion and aggregation of monocytes and may play a major regulatory role in granuloma formation (92) . These cells may therefore be involved in some cases of early resistance to microbial and parasite infection that have been associated with macrophage regulation. It would be worthwhile to investigate individual variations in the diversity of 7Ô-T cell receptors and the products released by 7Ô-TCR bearing cells.
Regulation of immune response mechanisms by cytokines
Once the immune response has been triggered by foreign antigen, it may proceed along different, often antagonistic pathways resulting in the selective activation of a whole array of effector mechanisms. Some effector mechanisms may be more efficient than others in combatting a certain disease agent, and the induction of the most appropriate immune response pathway may be of crucial importance in determining susceptibility or resistance to disease. The various factors controlling and directing the immune response have become an area of intense research in recent years, which has led to the identification, isolation and cloning of a number of products generally referred to as cytokines or lymphokines (94) . These include the interleukins, interferons, colony stimulating factors and tumour necrosis factors. Singly or in combination, these factors are responsible for a wide variety of events including recruitment and activation of effector cells. The importance of the differential induction of cytokines in disease resistance has been most clearly demonstrated in the murine model of leishmaniasis (62, 134). Susceptibility to this disease has been shown not to be MHC-linked. Although lymphocytes from the susceptible BALB/c strain proliferate more vigorously in response to the Leishmania antigen than lymphocytes from the C57BL/6 healer strain, they fail to control replication of the parasite resulting in a progressive fatal disease. It has recently been shown that separate helper T cell subsets (Th 1 and Th 2 ) are differentially induced in these two mouse strains, with only one subset (Th1) being effective in resolving infection (62, 134) . The difference between the effects of these two T cell subsets lies in the array of lymphokines produced by each subset. In addition, lymphokines produced by the non-protective Th 2 subset can actively suppress the generation of "protective" lymphokines produced by Th1 cells. Similar differential activation of helper T cell subsets and lymphokine production has been demonstrated to be a determining factor in non-MHC linked resistance to intestinal parasite infection (111) . It is expected that many more examples of similar cytokine-directed disease control will be established in the next few years. The importance of cytokine regulation should be considered when genes associated with disease resistance are investigated. Unfortunately, little is known as yet about the mechanisms or genes regulating the differential induction of cytokines or their receptors.
It would seem that selecting livestock for the preferential induction of a specific immune response effective against a particular type of pathogen, for example intestinal parasites, would lead to increased resistance to this infection. However, it should be kept in mind that an immune mechanism effective against one disease agent may be ineffective or even deleterious in protecting against a different pathogen. Selection criteria should therefore be tailored to the needs of the particular animal industry.
CONCLUSIONS
This review has focused on some of the recent advances in molecular genetics and the potential application of this technology to the animal industries. The development of a series of DNA markers that will identify genes controlling production traits or disease resistance requires a co-ordinated, international research effort. Given the rapid advancement of linkage analysis in man, the establishment of a gene linkage map in domestic animals is now realistic and achievable. The use of "reverse genetics", i.e. the identification of genes without prior knowledge of the causal mechanisms involved, has provided dramatic results in recent years. At the same time, there has been considerable advancement in our knowledge of the immunological processes involved in disease resistance. It is vitally important that studies aimed at elucidating the pathways determining disease resistance and important production traits be done in conjunction with molecular genetics.
The development of linkage maps and the establishment of marker-assisted trait selection programs will be of enormous benefit to animal breeders. The consequent use of high quality breeding stock will also benefit the general community, both by improving the efficiency of animal production and by reducing the effects of chemical residues in animal products and in the environment. Resumen: En los últimos años, se han realizado progresos importantes en la mejora del ganado gracias a la selección. Sin embargo, las técnicas de selección existentes aún se basan en largos y laboriosos programas de prueba de la descendencia y suelen reposar en una evaluación subjetiva del fenotipo. Actualmente, se están desarrollando nuevas técnicas de genética molecular para aislar e identificar los marcadores de ADN vinculados con los genes que codifican caracteres de importancia económica en ganadería y la resistencia a las enfermedades. Cuando estén disponibles, estos marcadores ofrecerán a los ganaderos pruebas objetivas para identificar los animales portadores de los genes deseados a su nacimiento o incluso antes. Los autores presentan brevemente algunas de estas nuevas técnicas, así como la manera en que se pueden aplicar a las industrias pecuarias. También se presentan algunos aspectos de los recientes progresos de nuestra comprensión del sistema inmunitario y los posibles mecanismos de control genético de la resistencia o la sensibilidad a las enfermedades animales. El artículo resume los conocimientos actuales sobre la resistencia/sensibilidad a las enfermedades, asociada o no con el complejo mayor de histocompatibilidad (CMH), en los animales domésticos, así como los mecanismos que podrían ser responsables de dicha asociación. El estudio de los marcadores genéticos relacionados con las enfermedades podría concernir los genes que controlan factores como la activación de los macrófagos, las citoquinas y los receptores de citoquinas y células yb-T. Por último, el objetivo será identificar los genes o los marcadores de ADN que puedan utilizarse para seleccionar, o crear, por ingeniería genética, linajes más productivos y resistentes a las enfermedades. 
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